India's cheap weight-loss drugs could reshape global obesity fight With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. https://www.bbc.com/news/articles/cx2g4411en3o?at_medium=RSS&at_campaign=rss (c) #BBC #News